18F-DCFPyl is a fluorine-18 labelled ligand binding specifically to PSMA. Developed by Johns Hopkins University (JHU), it allows imaging of prostate cancer and clear-cell renal-cell carcinoma (CCRCC).
The preparation of 18F-DCFPyl has been implemented jointly by Trasis and JHU on the AllinOne automated synthesizer. The process uses a cassette and a reagent kit.
- State-of-the-art yield
- No lab bench preparation
- Ready for use consumables
- Reduced operator exposure
|Cassette and reagents set up time||< 1 min|
|Synthesis time||60 min|
|Radiochemical purity||≥ 95|